cagrilintide semaglutide blend + Semaglutide + Cagrilintide Peptide |

The compound is currently in Phase 3 clinical trials and is not yet approved by the FDA or Health Canada

Someone reducing their dose would simply inject less total medication per week

Because obesity is not only about willpower

Joshua Levitt, a naturopathic doctor in Hamden, Connecticut

Both semaglutide and tirzepatide are well-known for their effects on weight loss and blood sugar control, but our study suggests they may also offer substantial benefits to patients with obesity and type 2 diabetes by reducing adverse heart failure outcomes. Despite promising results from existing randomized controlled trials of semaglutide and tirzepatide in those with obesity-related HFpEF, regulatory authorities and professional societies have not approved or endorsed the use of these drugs for HFpEF, due in part to the studies relatively small sample sizes and unknown generalizability

Personalized Fertility Planning with PlexusDx Genetic Testing PlexusDx's Precision Peptide Genetic Test identifies variations in genes like GLP1R, FTO, and MC4R that influence how your body responds to weight loss therapy and metabolic hormones